New Zealand markets closed

Medtronic plc (MDT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
81.04-0.60 (-0.73%)
At close: 04:00PM EDT
81.00 -0.04 (-0.05%)
Pre-market: 04:24AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 103.92B
Enterprise value 120.93B
Trailing P/E 29.36
Forward P/E 14.86
PEG ratio (5-yr expected) 1.54
Price/sales (ttm)3.33
Price/book (mrq)2.07
Enterprise value/revenue 3.74
Enterprise value/EBITDA 14.74

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3-7.01%
S&P500 52-week change 324.43%
52-week high 391.00
52-week low 368.84
50-day moving average 381.79
200-day moving average 381.11

Share statistics

Avg vol (3-month) 36.33M
Avg vol (10-day) 36.3M
Shares outstanding 51.28B
Implied shares outstanding 61.32B
Float 81.28B
% held by insiders 10.11%
% held by institutions 188.83%
Shares short (15 May 2024) 415.33M
Short ratio (15 May 2024) 42.78
Short % of float (15 May 2024) 41.17%
Short % of shares outstanding (15 May 2024) 41.17%
Shares short (prior month 15 Apr 2024) 412.39M

Dividends & splits

Forward annual dividend rate 42.8
Forward annual dividend yield 43.46%
Trailing annual dividend rate 32.76
Trailing annual dividend yield 33.38%
5-year average dividend yield 42.54
Payout ratio 4100.00%
Dividend date 312 Jul 2024
Ex-dividend date 428 Jun 2024
Last split factor 22:1
Last split date 327 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 26 Apr 2024
Most-recent quarter (mrq)26 Apr 2024


Profit margin 11.36%
Operating margin (ttm)17.17%

Management effectiveness

Return on assets (ttm)4.17%
Return on equity (ttm)7.26%

Income statement

Revenue (ttm)32.36B
Revenue per share (ttm)24.38
Quarterly revenue growth (yoy)0.50%
Gross profit (ttm)N/A
Net income avi to common (ttm)3.68B
Diluted EPS (ttm)2.76
Quarterly earnings growth (yoy)-44.50%

Balance sheet

Total cash (mrq)8.01B
Total cash per share (mrq)6.24
Total debt (mrq)26.05B
Total debt/equity (mrq)51.66%
Current ratio (mrq)2.03
Book value per share (mrq)38.29

Cash flow statement

Operating cash flow (ttm)6.79B
Levered free cash flow (ttm)5.23B